0 NYSE Companies - February 26, 2024CrossAmerica Partners LP Reports Fourth Quarter and Full Year 2023 ResultsAllentown, PA, Feb. 26, 2024 (GLOBE NEWSWIRE) — CrossAmerica Partners LP Reports Fourth Quarter and Full Year 2023 Results Reported […]Read More
0 Canadian Stock Exchange News - February 26, 2024Draganfly Announces Closing of US$3.6 Million Underwritten Public OfferingSaskatoon, SK., Feb. 26, 2024 (GLOBE NEWSWIRE) — Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8A) (“Draganfly” or the “Company”), […]Read More
0 NASDAQ Companies - February 26, 2024Sezzle Fourth-Quarter and Fiscal Year 2023 ResultsMinneapolis, MN, Feb. 26, 2024 (GLOBE NEWSWIRE) — Sezzle Inc. (NASDAQ:SEZL) (Sezzle or Company) // Purpose-driven digital payment platform, Sezzle, […]Read More
0 NASDAQ Companies - February 26, 2024South Plains Financial, Inc. Announces Stock Repurchase ProgramLUBBOCK, Texas, Feb. 26, 2024 (GLOBE NEWSWIRE) — South Plains Financial, Inc. (NASDAQ:SPFI) (“South Plains” or the “Company”), today announced […]Read More
0 NASDAQ Companies - February 26, 2024Snap One Holdings Corp. to Report Fiscal Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 7, 2024 at 4:30 p.m. ETCHARLOTTE, N.C. , Feb. 26, 2024 (GLOBE NEWSWIRE) — Snap One Holdings Corp. (Nasdaq: SNPO) (“Snap One” or the “Company”), […]Read More
0 NASDAQ Companies - February 26, 2024SI-BONE, Inc. Reports Record Fourth Quarter and Full Year 2023 Financial Results and Issues 2024 GuidanceSANTA CLARA, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) — SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving […]Read More
0 NASDAQ Companies - February 26, 2024FibroGen Reports Fourth Quarter and Full Year 2023 Financial Results• Topline data from two pivotal pamrevlumab pancreatic cancer trials anticipated in 2Q 2024 • Additional data from Phase 1 monotherapy study […]Read More
0 NASDAQ Companies - February 26, 2024Revolution Medicines Reports Fourth Quarter and Full Year 2023 Financial Results and Update on Corporate ProgressREDWOOD CITY, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted […]Read More
0 NASDAQ Companies - February 26, 2024Codexis Enters Exclusive Licensing Agreement for Newly Engineered Double-Stranded DNA Ligase with RocheREDWOOD CITY, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced […]Read More
0 NASDAQ Companies - February 26, 2024Jimmy Lee Appointed As Chairman Emeritus Of Mercer International Inc.NEW YORK, Feb. 26, 2024 (GLOBE NEWSWIRE) — Mercer International Inc. (“Mercer” or the “Company”) (Nasdaq: MERC) announced that Jimmy […]Read More